Analogs of the ATP-Sensitive Potassium (KATP) Channel Opener Cromakalim with in Vivo Ocular Hypotensive Activity

Uttio Roy Chowdhury, Kimberly B. Viker, Kristen L. Stoltz, Bradley H. Holman, Michael P Fautsch, Peter I. Dosa

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

ATP-sensitive potassium (KATP) channel openers have emerged as potential therapeutics for the treatment of glaucoma, lowering intraocular pressure (IOP) in animal models and cultured human anterior segments. We have prepared water-soluble phosphate and dipeptide derivatives of the KATP channel opener cromakalim and evaluated their IOP lowering capabilities in vivo. In general, the phosphate derivatives proved to be more chemically robust and efficacious at lowering IOP with once daily dosing in a normotensive mouse model. Two of these phosphate derivatives were further evaluated in a normotensive rabbit model, with a significant difference in activity observed. No toxic effects on cell structure or alterations in morphology of the aqueous humor outflow pathway were observed after treatment with the most efficacious compound, (3S,4R)-2, suggesting that it is a strong candidate for development as an ocular hypotensive agent.

Original languageEnglish (US)
Pages (from-to)6221-6231
Number of pages11
JournalJournal of Medicinal Chemistry
Volume59
Issue number13
DOIs
StatePublished - Jul 14 2016

Fingerprint

Cromakalim
KATP Channels
Intraocular Pressure
Phosphates
Aqueous Humor
Dipeptides
Poisons
Glaucoma
Animal Models
Rabbits
Water
Therapeutics

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Analogs of the ATP-Sensitive Potassium (KATP) Channel Opener Cromakalim with in Vivo Ocular Hypotensive Activity. / Roy Chowdhury, Uttio; Viker, Kimberly B.; Stoltz, Kristen L.; Holman, Bradley H.; Fautsch, Michael P; Dosa, Peter I.

In: Journal of Medicinal Chemistry, Vol. 59, No. 13, 14.07.2016, p. 6221-6231.

Research output: Contribution to journalArticle

Roy Chowdhury, Uttio ; Viker, Kimberly B. ; Stoltz, Kristen L. ; Holman, Bradley H. ; Fautsch, Michael P ; Dosa, Peter I. / Analogs of the ATP-Sensitive Potassium (KATP) Channel Opener Cromakalim with in Vivo Ocular Hypotensive Activity. In: Journal of Medicinal Chemistry. 2016 ; Vol. 59, No. 13. pp. 6221-6231.
@article{117381fe953845caa13871ac9f836c37,
title = "Analogs of the ATP-Sensitive Potassium (KATP) Channel Opener Cromakalim with in Vivo Ocular Hypotensive Activity",
abstract = "ATP-sensitive potassium (KATP) channel openers have emerged as potential therapeutics for the treatment of glaucoma, lowering intraocular pressure (IOP) in animal models and cultured human anterior segments. We have prepared water-soluble phosphate and dipeptide derivatives of the KATP channel opener cromakalim and evaluated their IOP lowering capabilities in vivo. In general, the phosphate derivatives proved to be more chemically robust and efficacious at lowering IOP with once daily dosing in a normotensive mouse model. Two of these phosphate derivatives were further evaluated in a normotensive rabbit model, with a significant difference in activity observed. No toxic effects on cell structure or alterations in morphology of the aqueous humor outflow pathway were observed after treatment with the most efficacious compound, (3S,4R)-2, suggesting that it is a strong candidate for development as an ocular hypotensive agent.",
author = "{Roy Chowdhury}, Uttio and Viker, {Kimberly B.} and Stoltz, {Kristen L.} and Holman, {Bradley H.} and Fautsch, {Michael P} and Dosa, {Peter I.}",
year = "2016",
month = "7",
day = "14",
doi = "10.1021/acs.jmedchem.6b00406",
language = "English (US)",
volume = "59",
pages = "6221--6231",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "13",

}

TY - JOUR

T1 - Analogs of the ATP-Sensitive Potassium (KATP) Channel Opener Cromakalim with in Vivo Ocular Hypotensive Activity

AU - Roy Chowdhury, Uttio

AU - Viker, Kimberly B.

AU - Stoltz, Kristen L.

AU - Holman, Bradley H.

AU - Fautsch, Michael P

AU - Dosa, Peter I.

PY - 2016/7/14

Y1 - 2016/7/14

N2 - ATP-sensitive potassium (KATP) channel openers have emerged as potential therapeutics for the treatment of glaucoma, lowering intraocular pressure (IOP) in animal models and cultured human anterior segments. We have prepared water-soluble phosphate and dipeptide derivatives of the KATP channel opener cromakalim and evaluated their IOP lowering capabilities in vivo. In general, the phosphate derivatives proved to be more chemically robust and efficacious at lowering IOP with once daily dosing in a normotensive mouse model. Two of these phosphate derivatives were further evaluated in a normotensive rabbit model, with a significant difference in activity observed. No toxic effects on cell structure or alterations in morphology of the aqueous humor outflow pathway were observed after treatment with the most efficacious compound, (3S,4R)-2, suggesting that it is a strong candidate for development as an ocular hypotensive agent.

AB - ATP-sensitive potassium (KATP) channel openers have emerged as potential therapeutics for the treatment of glaucoma, lowering intraocular pressure (IOP) in animal models and cultured human anterior segments. We have prepared water-soluble phosphate and dipeptide derivatives of the KATP channel opener cromakalim and evaluated their IOP lowering capabilities in vivo. In general, the phosphate derivatives proved to be more chemically robust and efficacious at lowering IOP with once daily dosing in a normotensive mouse model. Two of these phosphate derivatives were further evaluated in a normotensive rabbit model, with a significant difference in activity observed. No toxic effects on cell structure or alterations in morphology of the aqueous humor outflow pathway were observed after treatment with the most efficacious compound, (3S,4R)-2, suggesting that it is a strong candidate for development as an ocular hypotensive agent.

UR - http://www.scopus.com/inward/record.url?scp=84978768065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978768065&partnerID=8YFLogxK

U2 - 10.1021/acs.jmedchem.6b00406

DO - 10.1021/acs.jmedchem.6b00406

M3 - Article

C2 - 27367033

AN - SCOPUS:84978768065

VL - 59

SP - 6221

EP - 6231

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 13

ER -